ANTHEIA
Antheia is a biotechnology company unlocking the medicinal power of nature with its rapid response biomanufacturing processes for essential medicines. Antheia uses synthetic biology to surpass the limits of conventional drug manufacturing and discovery. By reconstructing complex molecules in yeast, Antheia can produce APIs without the use of medicinal plants, transforming the pharmaceutical supply chain and ensuring reliable, consistent, and widespread availability to essential medicines.
ANTHEIA
Social Links:
Industry:
Biotechnology Health Care Manufacturing
Founded:
2015-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.antheia.bio
Total Employee:
11+
Status:
Active
Contact:
650-353-5191
Email Addresses:
[email protected]
Total Funding:
152.1 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Font Awesome
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Medtrica
Medtrica is a medical manufacturing company with operations facilities located in Langley, British Columbia.
Mindstate Design Labs
Mindstate Design Labs is a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics.
Retainer Club
Retainer Club is a subscription healthcare business that manufactures 3-D printed custom retainers, mouth guards and night guards.
Current Employees Featured
Founder
Investors List
Viking Global Investors
Viking Global Investors investment in Venture Round - Antheia
BioMaP-Consortium
BioMaP-Consortium investment in Grant - Antheia
Echo Investment Capital
Echo Investment Capital investment in Venture Round - Antheia
In-Q-Tel
In-Q-Tel investment in Venture Round - Antheia
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - Antheia
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Antheia
Hillspire
Hillspire investment in Series B - Antheia
Viking Global Investors
Viking Global Investors investment in Series B - Antheia
Irregular Expressions
Irregular Expressions investment in Series B - Antheia
Sherpalo Ventures
Sherpalo Ventures investment in Series B - Antheia
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-18 | Antheia Appoints Zack McGahey as Chief Operating Officer |
Official Site Inspections
http://www.antheia.bio Semrush global rank: 4.2 M Semrush visits lastest month: 2.39 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Antheia"
Antheia, Inc. - LinkedIn
Antheia is the next-generation pharmaceutical ingredient producer with a mission to end drug shortages. Using advanced biosynthesis and fermentation technology, Antheia’s biomanufacturing ...See details»
Antheia - Crunchbase Company Profile & Funding
Organization. Antheia . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
Antheia: Contact Details, Revenue, Funding, Employees and …
Nov 12, 2024 Antheia is transforming pharmaceutical supply chains by using synthetic biology to engineer complex molecules in yeast, enabling the development of plant-inspired medicines. …See details»
Antheia 2025 Company Profile: Valuation, Funding
Antheia General Information Description. Operator of a biotechnology company intended to develop plant-inspired medicines. The company's cost …See details»
Antheia Raises $56 Million in Series C Financing to Fuel Global ...
Jun 3, 2025 For more information on how Antheia is transforming pharmaceutical supply chains, visit www.antheia.bio. MEDIA CONTACT: Mission North for Antheia [email protected] …See details»
GHIC Co-Leads Antheia’s $56M Series C Financing to Strengthen ...
Jun 4, 2025 New York, NY – Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced it has raised $56 million in Series C …See details»
About Us - Antheia
Antheia was founded in 2015 out of the Smolke Lab at Stanford University on the premise that yeast could be programmed to efficiently produce complex pharmaceutical ingredients. Founders Dr. Christina Smolke, CEO and Dr. …See details»
Female-Founded Antheia Raises $73 Million to Support ... - BioSpace
Jun 30, 2021 Synthetic biology startup Antheia raised $73 million in Series B financing to support the company’s efforts to bring its first plant-based medicine to market and support the …See details»
Antheia - workinbiotech.com
Antheia is developing next generation medicines inspired by plants. Manufacturing therapies to heal people of disease doesn’t have to be unsustainable. Antheia is focused on identifying …See details»
Antheia Lands $12M with Second BioMaP Deal to Reshape U.S.
Dec 3, 2024 Antheia’s innovation aligns with the BioMaP-Consortium’s mission to strengthen the U.S. pharmaceutical and vaccine supply chain. By integrating raw material suppliers, cutting …See details»
Antheia raises $17m to support pharmaceutical production
Photo: antheia.bio/media-kit The combined funding will support onshoring the production of critical pharmaceutical ingredients to the US and accelerating the company’s commercialisation …See details»
Antheia Achieves Major Commercial Milestone - PR Newswire
Aug 24, 2023 Antheia's pipeline aligns with the U.S. Food and Drug Administration and the World Health Organization's Essential Medicines lists and the company's platform supports …See details»
Antheia Completes Successful Product Validation
Menlo Park, CA – January 8, 2024 – Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced it has completed a …See details»
Antheia Raises $56 Million in Series C Financing to Fuel Global ...
Jun 4, 2025 Founded in 2015, Antheia has grown into a commercial stage company with its first product to market, an active customer pipeline, and near-term product launches. For more …See details»
Careers - Antheia
Before Antheia, he led quality efforts at Zymergen and Sandoz, and supported many global pharmaceutical companies during his time in Biotech Consulting at NSF International, all to …See details»
Antheia Announces $73M Series B to Commercialize Synthetic …
Jul 1, 2021 Led by Viking Global Investors, the Series B round will be used to bring Antheia's first pharmaceutical compounds to market, expand its pipeline and scale production in global …See details»
Antheia’s 2024 in Review: A Year Of Collaboration - Antheia
Dec 20, 2024 As we reflect on 2024, it’s been a significant year of collaboration, with every Antheia employee and partner helping us move closer toward our mission of transforming …See details»
Antheia Achieves Major Commercial Milestone - Antheia
Aug 21, 2023 About Antheia Antheia is the next-generation pharmaceutical ingredient producer transforming essential medicine supply chains to end drug shortages. Using its novel whole …See details»
Celebrating Antheia’s Series C Financing
Jun 3, 2025 Farrah leads program and project management at Antheia. She has over 20 years of experience leading program and project management, operations, and engineering for …See details»
BIO 2025: Progress can't wait. | BIO - bio.org
1 day ago BIO 2025 started with a multi-panel session featuring officials from the Administration for Strategic Preparedness and Response (ASPR) and the Department of Defense about how …See details»